肝脏 ›› 2026, Vol. 31 ›› Issue (9): 1293-1298.

• 肝癌 • 上一篇    下一篇

经皮射频消融辅助肝脏分隔改良二步肝切除术治疗临界可切除肝癌的转化治疗效果

陈尧, 何彦安, 唐波, 朱永   

  1. 621799 绵阳 江油市人民医院肝胆外科(陈尧,何彦安,唐波);
    611130 成都 成都市第五人民医院肝胆外科(朱永)
  • 收稿日期:2025-10-16 出版日期:2026-09-30 发布日期:2026-11-16
  • 通讯作者: 陈尧,Email: nnnb6fl@163.com
  • 基金资助:
    2020年四川省医学青年创新科研课题(S20131)

Translational therapeutic effect of percutaneous radiofrequency ablation-assisted modified two-step hepatectomy with liver separation in the treatment of borderline resectable liver cancer

Chen Yao1, He Yan'an1, Tang Bo1, Zhu Yong2   

  1. 1. Department of Hepatobiliary Surgery, Jiangyou People's Hospital, Mianyang 621799,China;
    2. Department of Hepatobiliary Surgery,Chengdu Fifth People's Hospital, Chengdu 611130,China
  • Received:2025-10-16 Online:2026-09-30 Published:2026-11-16
  • Contact: Chen Yao,Email: nnnb6fl@163.com

摘要: 目的 探究经皮射频消融(PRFA)辅助肝脏分隔改良二步肝切除术治疗临界可切除肝癌的转化治疗效果。方法 选取2022年3月至2024年3月四川省江油市人民医院收治的86例临界可切除肝癌患者进行前瞻性队列研究。采用随机数字表法将患者分为2组,对照组(n=43)行传统联合肝脏分隔和门静脉结扎二步肝切除术(ALPPS),观察组(n=43)在ALPPS的一期手术肝脏分隔时采用PRFA辅助分隔。统计患者围手术期指标,对比两组术后肝功能及肝体积变化情况,统计患者术后并发症情况。所有患者随访1年,统计复发及无进展生存情况。结果 与对照组比较,观察组一期手术时间[(217.26±35.37)比(141.22±23.54)h]、术中失血量[(378.56±85.46)比(95.33±10.29)mL]、切口长度[(23.97±4.35)比(17.25±3.66)cm]及二期术中失血量[(638.71±85.43)比(545.26±80.95)mL]均降低,手术间隔[(18.26±3.71)比 (15.21±4.95)d]及住院时间[(15.95±2.06)比(13.35±2.33)d]均缩短(P<0.05)。与对照组比较,观察组一期术后1 d的丙氨酸氨基转移酶、天冬氨酸氨基转移酶水平升高[(659.43±61.26)比(890.56±55.79)U/L;(584.59±62.43)比(675.56±96.51)U/L](P<0.05)。两组各时间点剩余肝体积及FLR占标准肝体积的百分比水平差异无统计学意义(P>0.05)。观察组一期术后胆漏及术后并发症总发生率均低于对照组(13.95% 比0;41.86% 比16.28%)(P<0.05)。观察组术后复发率(17.50%)低于对照组(21.05%)(χ2=0.158,P=0.691)。Kaplan-Meier生存分析显示,两组无进展生存曲线比较,差异无统计学意义(Log-Rank χ2=0.121,P=0.718)。结论 PRFA辅助ALPPS治疗临界可切除肝癌患者能够减少一期术中出血量及切口长度,缩短手术时间、手术间隔及住院时间,增加术后肝体积,减少一期并发症的发生。

关键词: 经皮射频消融, 联合肝脏分隔和门静脉结扎二步肝切除术, 临界可切除肝癌, 剩余肝体积

Abstract: Objective This study aimed to explore the translational therapeutic effect of percutaneous radiofrequency ablation (PRFA) -assisted modified two-step hepatectomy with liver separation in the treatment of borderline resectable liver cancer. Methods A prospective cohort study was conducted on 86 patients with borderline resectable liver cancer admitted to Jiangyou People's Hospital, Sichuan Province from March 2022 to March 2024. They were randomly divided into 2 groups by the random number table method. The control group (n=43) underwent traditional associating liver partition and portal vein ligation for staged hepatectomy (ALPPS). The observation group (n=43) used PRFA-assisted liver separation in the first stage of ALPPS. The perioperative indicators of the patients were statistically analyzed. The changes in liver function and liver volume after surgery between the two groups were compared, and the postoperative complications of the patients were statistically analyzed. All patients were followed up for one year, and the recurrence and progression-free survival of the patients during this period were statistically analyzed. Results Compared with the control group, the operation time of the first stage [(217.26±35.37) vs. (141.22±23.54) h], intraoperative blood loss [(378.56±85.46) vs. (95.33±10.29) mL], incision length [(23.97±4.35) vs. (17.25±3.66) cm], intraoperative blood loss in the second stage [(638.71±85.43) vs. (545.26±80.95) mL], the interval between procedures [(18.26±3.71) vs. (15.21±4.95) d] and length of hospital stay [(15.95±2.06) vs. (13.35±2.33) d] were shortened (P<0.05). Compared with the control group, the levels of ALT and AST in the observation group increased [(659.43±61.26) vs. (890.56±55.79) U/L at 1 day after the first stage of operation (584.59±62.43) vs.(675.56±96.51) U/L](P<0.05). There was no statistically significant difference in FLR and F/S levels between the two groups at each time point (P<0.05). The total incidence of postoperative bile leakage and postoperative complications in the observation group was lower than that in the control group (13.95% vs.0; 41.86% vs. 16.28%) (P<0.05). The postoperative recurrence rate in the observation group (17.50%) was lower than that in the control group (21.05%) (χ2=0.158, P=0.691). Kaplan-Meier survival analysis showed that there was no statistically significant difference in the progression-free survival curves between the two groups (Log-Rank χ2=0.121, P=0.718). Conclusion PRFA-assisted ALPPS in the treatment of borderline resectable liver cancer patients can reduce intraoperative blood loss and incision length, shorten operation time, operation interval and hospital stay, increase postoperative liver volume, and reduce the occurrence of primary complications.

Key words: Percutaneous radiofrequency ablation, Associating liver partition and portal vein ligation for staged hepatectomy, Borderline resectable, Liver cancer, Residual liver volume